Determinants of Patient Refusal of Postoperative Radiation Therapy in Sinonasal Squamous Cell Carcinoma.

IF 0.9 4区 医学 Q3 Medicine Journal of Neurological Surgery Part B: Skull Base Pub Date : 2023-06-01 DOI:10.1055/a-1780-4157
Rijul S Kshirsagar, Jacob G Eide, Aman Prasad, Ryan M Carey, Karthik Rajasekaran, Jason A Brant, Jason G Newman, James N Palmer, Nithin D Adappa
{"title":"Determinants of Patient Refusal of Postoperative Radiation Therapy in Sinonasal Squamous Cell Carcinoma.","authors":"Rijul S Kshirsagar,&nbsp;Jacob G Eide,&nbsp;Aman Prasad,&nbsp;Ryan M Carey,&nbsp;Karthik Rajasekaran,&nbsp;Jason A Brant,&nbsp;Jason G Newman,&nbsp;James N Palmer,&nbsp;Nithin D Adappa","doi":"10.1055/a-1780-4157","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objectives</b>  Although adjuvant radiotherapy may be indicated in patients with sinonasal squamous cell carcinoma (SNSCC) following primary surgery, some patients choose to forgo recommended postoperative radiation therapy (PORT). This study aimed to elucidate factors associated with patient refusal of recommended PORT in SNSCC and examine overall survival. <b>Methods</b>  Retrospective analysis of patients with SNSCC treated with primary surgery from the National Cancer Database diagnosed between 2004 and 2016. A multivariable logistic regression model was created to determine the association between clinical or demographic covariates and likelihood of PORT refusal. Unadjusted Kaplan-Meier estimates, log-rank tests, and a multivariable Cox proportional hazard model were used to assess overall survival. <b>Results</b>  A total of 2,231 patients were included in the final analysis, of which 1,456 (65.3%) were males and 73 (3.3%) refused recommended PORT. Patients older than 74 years old were more likely to refuse PORT than those younger than 54 (odds ratio [OR] 3.43, 95% confidence interval [CI]: 1.84-6.62). Median survival among the entire cohort, those who received recommended PORT, and those who refused PORT was 83.0 months (95% CI: 74.6-97.1), 83.0 months (95% CI: 74.9-98.2), and 63.6 months (95% CI: 37.3-101.4), respectively. Refusal of PORT was not associated with overall survival (hazard ratio: 0.99, 95% CI: 0.69-1.42). <b>Conclusions</b>  PORT refusal in patients with SNSCC is rare and was found to be associated with several patient factors. The decision to forgo PORT is not independently associated with overall survival in this cohort. Further study is required to determine the clinical implications of these findings as the treatment decisions are complex.</p>","PeriodicalId":16513,"journal":{"name":"Journal of Neurological Surgery Part B: Skull Base","volume":"84 3","pages":"232-239"},"PeriodicalIF":0.9000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171933/pdf/10-1055-a-1780-4157.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurological Surgery Part B: Skull Base","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-1780-4157","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Objectives  Although adjuvant radiotherapy may be indicated in patients with sinonasal squamous cell carcinoma (SNSCC) following primary surgery, some patients choose to forgo recommended postoperative radiation therapy (PORT). This study aimed to elucidate factors associated with patient refusal of recommended PORT in SNSCC and examine overall survival. Methods  Retrospective analysis of patients with SNSCC treated with primary surgery from the National Cancer Database diagnosed between 2004 and 2016. A multivariable logistic regression model was created to determine the association between clinical or demographic covariates and likelihood of PORT refusal. Unadjusted Kaplan-Meier estimates, log-rank tests, and a multivariable Cox proportional hazard model were used to assess overall survival. Results  A total of 2,231 patients were included in the final analysis, of which 1,456 (65.3%) were males and 73 (3.3%) refused recommended PORT. Patients older than 74 years old were more likely to refuse PORT than those younger than 54 (odds ratio [OR] 3.43, 95% confidence interval [CI]: 1.84-6.62). Median survival among the entire cohort, those who received recommended PORT, and those who refused PORT was 83.0 months (95% CI: 74.6-97.1), 83.0 months (95% CI: 74.9-98.2), and 63.6 months (95% CI: 37.3-101.4), respectively. Refusal of PORT was not associated with overall survival (hazard ratio: 0.99, 95% CI: 0.69-1.42). Conclusions  PORT refusal in patients with SNSCC is rare and was found to be associated with several patient factors. The decision to forgo PORT is not independently associated with overall survival in this cohort. Further study is required to determine the clinical implications of these findings as the treatment decisions are complex.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
鼻窦鳞状细胞癌术后患者拒绝放射治疗的影响因素。
虽然鼻窦鳞状细胞癌(SNSCC)患者在初次手术后可能需要辅助放疗,但一些患者选择放弃推荐的术后放疗(PORT)。本研究旨在阐明SNSCC患者拒绝推荐PORT的相关因素,并检查总生存率。方法回顾性分析2004年至2016年国家癌症数据库中诊断为原发性手术的SNSCC患者。建立了一个多变量logistic回归模型来确定临床或人口统计学协变量与PORT拒绝可能性之间的关系。未校正Kaplan-Meier估计、log-rank检验和多变量Cox比例风险模型用于评估总生存率。结果最终纳入2231例患者,其中男性1456例(65.3%),拒绝推荐PORT的73例(3.3%)。年龄大于74岁的患者比年龄小于54岁的患者更有可能拒绝PORT(优势比[OR] 3.43, 95%可信区间[CI]: 1.84-6.62)。整个队列、接受推荐的PORT和拒绝PORT的中位生存期分别为83.0个月(95% CI: 74.6-97.1)、83.0个月(95% CI: 74.9-98.2)和63.6个月(95% CI: 37.3-101.4)。拒绝PORT与总生存率无关(风险比:0.99,95% CI: 0.69-1.42)。结论:SNSCC患者拒绝PORT手术是罕见的,与多种患者因素有关。在该队列中,放弃PORT的决定与总生存率没有独立的相关性。由于治疗决策复杂,需要进一步研究来确定这些发现的临床意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
516
期刊介绍: The Journal of Neurological Surgery Part B: Skull Base (JNLS B) is a major publication from the world''s leading publisher in neurosurgery. JNLS B currently serves as the official organ of several national and international neurosurgery and skull base societies. JNLS B is a peer-reviewed journal publishing original research, review articles, and technical notes covering all aspects of neurological surgery. The focus of JNLS B includes microsurgery as well as the latest minimally invasive techniques, such as stereotactic-guided surgery, endoscopy, and endovascular procedures. JNLS B is devoted to the techniques and procedures of skull base surgery.
期刊最新文献
Characterizing Hearing Outcomes Following Treatment of Cerebellopontine Angle Meningiomas Deskeletonizing the Sigmoid Sinus Is Noncompulsory in Skull Base Surgery: 3D Modeling of the Translabyrinthine Approach Supra Digastric Muscles Approach for Styloid Process Resection A Multicenter Study of Unplanned Hospital Readmissions after Transsphenoidal Surgery for Cushing's Disease Careers in Skull Base and Open Cerebrovascular Surgery: Factors Associated with Academic Job Placement
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1